|Previous||1 of 1||Next|
small (250x250 max)
medium (500x500 max)
large ( > 500x500)
Oklahoma Immunization Update August 2013 PREVENTION and PREPAREDNESS SERVICES IMMUNIZATION SERVICE PLEASE POST & DISTRIBUTE TO ALL NURSING AND MEDICAL STAFF Sign Up to Receive this Update by E-Mail Subscribe at: https://public.govdelivery.com/accounts/OKSDH/subscriber/new?topic_id=OKSDH_79. All interested staff may subscribe, as there is no limit to the number of subscribers. You may cancel your subscription at any time. Children & Adolescent Medical Services in Tulsa Increases Childhood Immunization Level to 87% Congratulations to the staff and physicians of Children & Adolescent Medical Services in Tulsa for increasing the percentage of children seen in their clinic who are up-to-date from 65% in 2012 to 87% in 2013. This level surpasses the 2020 Healthy People goal of 80% of children 19 through 35 months of age up-to-date with 4 DTaP, 3 polio, 1 MMR, 3 Hib, 3 HepB, and 1 varicella. The clinic staff reports they reached this level through the following steps: · Using their list of SoonerCare clients they checked the immunization status of all children in OSIIS; · If a child was not up-to-date, the staff telephoned the parents and made an appointment for the child to receive vaccines; · After all the records had been reviewed initially, the staff reviewed the Oklahoma State Immunization Information System (OSIIS) Missed Opportunities Report every month and contacted the parents of children listed on the report. The Immunization Service appreciates the extra effort put forth by the staff of Children & Adolescent Medical Services. Influenza Vaccine Viruses for 2013-14 Trivalent vaccines will contain: · A/California/7/2009 (H1N1)-like virus, · An A/(H3N2) virus antigenically like cell propagated A/Victoria/361/2011 virus (A/Texas/50/2012), and · B/Massachusetts/2/2012-like virus (Yamagata lineage). Quadrivalent vaccines, in addition to the above, will also contain a B/Brisbane/60/2008-like virus (Victoria lineage). ACIP Recommends an Influenza Vaccine Option for People with Egg Allergy The Advisory Committee on Immunization Practices (ACIP) voted at their June 2013 meeting in favor of recommending Flublok® as the preferred vaccine for persons 18 through 49 years of age with egg allergy of any severity during the 2013-2014 influenza season. Flublok, manufactured by Protein Sciences Corporation, was licensed by the Food and Drug Administration (FDA) on January 16, 2013 and eggs are not used at any point in the manufacturing process. · Flublok is manufactured using new technology that does not require the use of actual influenza viruses or eggs. · Flublok uses three recombinant hemagglutinin (HA) proteins representing two influenza virus A strains, H1N1 and H3N2, and one influenza virus B strain to trigger the immune response. · While the technology is new to flu vaccine production, it is used to make vaccines that have been approved by the FDA to prevent other infectious diseases. Flublok’s safety was evaluated in a study of approximately 2,500 people. The most commonly reported adverse events included pain at the site of injection (37%), headache (15%), fatigue (15%) and muscle aches, events also typical for conventional egg-based, inactivated influenza vaccines. Health care providers should note that Flublok has a shorter shelf life, with an expiration period of 16 weeks from the production date, as compared to currently available inactivated influenza vaccines which carry an expiration date of June 30 the following year. Health care providers should check the expiration date before administering Flublok. The abbreviation for the type of vaccine represented by Flublok is RIV3 (recombinant hemagglutinin influenza vaccine, trivalent). The Flublok package insert is available at: http://www.fda.gov/downloads/BiologicsBloodVaccines/V accines/ApprovedProducts/UCM336020.pdf. Flublok is not available through the Vaccines for Children Program in Oklahoma. Sources: http://www.fda.gov/NewsEvents/Newsroom/PressAnnounceme nts/ucm335891.htm http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccin es/ApprovedProducts/UCM336020.pdf For an online version of this Update, visit the Immunization Service web page at: http://www.ok.gov/health/Disease,_Prevention,_Preparedness/Immunizations/Information_for_Health_Professionals/index.html. If you have any questions about this material, contact the Immunization Service by telephone at 405.271.4073 or by e-mail at email@example.com.
|Okla State Agency||
Health, Oklahoma State Department of
|Okla Agency Code||
|Title||Oklahoma immunization update, 08/2013|
Oklahoma. Immunization Service.
|Purpose||Children & Adolescent Medical Services in Tulsa Increases Childhood Immunization Level to 87%; Influenza Vaccine Viruses for 2013-14; ACIP Recommends an Influenza Vaccine Option for People with Egg Allergy;|
|For all issues click||
|Digital Format||PDF, Adobe Reader required|
|ODL electronic copy||Downloaded from agency website: http://www.ok.gov/health2/documents/IMM_Update_2013_August.pdf|
|Rights and Permissions||This Oklahoma state government publication is provided for educational purposes under U.S. copyright law. Other usage requires permission of copyright holders.|